SCHEMBL10838059

SCHEMBL10838059

O=C(c1ccccc1Nc1ccncc1)N1CCCCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.62
▸ NPSR1 Q6W5P4 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ CYP2C9 P11712 2/20 0.62
▸ HTT P42858 2/20 0.62
▸ L3MBTL1 Q9Y468 2/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ CYP1A2 P05177 1/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ CYP2D6 P10635 1/20 0.62
▸ CYP2C19 P33261 1/20 0.62
▸ ADRA1A P35348 2/20 0.52
▸ ADRA1B P35368 2/20 0.52
▸ ADRA1D P25100 1/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ MAPT P10636 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ofornine SCHEMBL120272 1.00 LMNA (0.62) LMNANPSR1KMT2ACYP2C9HTT
Ofornine SCHEMBL30560632 1.00 LMNA (0.62) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10838011 1.00 LMNA (0.62) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10837621 0.99 LMNA (0.60) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10838123 0.86 LMNA (0.63) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10838817 0.86 SMN1; SMN2 (0.56) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10838784 0.85 NPSR1 (0.50) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10990701 0.84 NPSR1 (0.67) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10838194 0.84 SMO (0.49) LMNANPSR1KMT2ACYP2C9HTT
SCHEMBL10837980 0.84 KMT2A (0.47) LMNANPSR1KMT2ACYP2C9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4610991-A Antihypertensive pyridylaminobenzamide compounds STERLING DRUG INC. (US) 1986-09-09 — — US claimed
US-4610991-A Antihypertensive pyridylaminobenzamide compounds STERLING DRUG INC. (US) 1986-09-09 — — US disclosed
EP-0098951-A2 Aminobenzamide derivatives and preparation thereof STERLING DRUG INC. (US) 1984-01-25 — — EP disclosed
Send feedback